Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age - Related Studies

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

This study has been completed.

Study NCT00345579. Last updated on October 31, 2008. Information provided by GlaxoSmithKline

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Haemophilus Influenza Infections
		Meningococcal Infection

2	Additional conditions recognized in this trial
		Communicable Diseases
		Infection
		Influenza, Human
		Meningococcal Infections

3	More general conditions related to this trial
		Bacterial Infections
		Gram-Negative Bacterial Infections
		Neisseriaceae Infections
		Orthomyxoviridae Infections
		Respiratory Tract Diseases
		Respiratory Tract Infections
		RNA Virus Infections
		Virus Diseases

4	Interventions listed in this trial
		Pediarix/Infanrix Penta
		ActHIB

5	Sponsors listed in this trial
		GlaxoSmithKline